70771-1753Level 3
Mirabegron (Mirabegron)
**Product type:** Human Prescription Drug
**Active ingredient:** MIRABEGRON
**Strength:** 50 mg/1
**Dosage form:** Tablet, Extended Release
**Route:** Oral
**Labeler:** Zydus Lifesciences Limited
**Marketing category:** ANDA (ANDA209488)
**Pharmacologic class:** Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/70771-1753Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.